Thrivent Financial for Lutherans

Position in NVS — Novartis AG

CIK 314984 Minneapolis, MN

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,362,523

+$278,304 QoQ

Shares Held

8,694

+22.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#534

of 1,603 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Thrivent Financial for Lutherans holds $1,673,064,906 across 14 Drug Manufacturers - General names. NVS ranks #11 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	396,540	$475,622,010
2	JNJ	Johnson & Johnson	1,458,722	$370,471,625
3	MRK	Merck & Co., Inc.	2,340,397	$300,741,013
4	AMGN	Amgen Inc	494,025	$178,896,331
5	GILD	Gilead Sciences, Inc.	876,893	$110,786,660
6	ABBV	AbbVie Inc.	391,576	$98,536,182
7	BMY	Bristol Myers Squibb Co	1,147,117	$66,096,880
8	AZN	Astrazeneca PLC	282,337	$53,536,741

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,362,523	8,694	+22.5%	Shares	Sole	2026-08-14
2026-03-31	$1,084,219	7,098	+267.2%	Shares	Sole	2026-05-01
2025-03-31	$215,490	1,933	0.0%	Shares	Sole	2025-08-26
2024-12-31	$188,100	1,933	-16.0%	Shares	Sole	2025-02-10
2023-03-31	$211,692	2,301	-3.1%	Shares	Sole	2023-05-17
2022-12-31	$215,460	2,375	0.0%	Shares	Sole	2023-02-08
2022-06-30	$200,758	2,375	-56.1%	Shares	Sole	2022-08-16
2022-03-31	$475,253	5,416	+101.4%	Shares	Sole	2022-05-13
2020-12-31	$253,922	2,689	-1.2%	Shares	Sole	2021-02-16
2020-06-30	$237,826	2,723	0.0%	Shares	Sole	2020-08-12
2020-03-31	$224,511	2,723	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.